Mn Services Vermogensbeheer B.V. Has $9.50 Million Stake in Mettler-Toledo International, Inc. (NYSE:MTD)

Mn Services Vermogensbeheer B.V. lowered its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 4.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,048 shares of the medical instruments supplier's stock after selling 400 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in Mettler-Toledo International were worth $9,504,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in MTD. Alliancebernstein L.P. lifted its holdings in shares of Mettler-Toledo International by 9.9% during the fourth quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock worth $713,627,000 after buying an additional 52,726 shares during the last quarter. Geode Capital Management LLC boosted its stake in Mettler-Toledo International by 2.0% in the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after buying an additional 11,032 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Mettler-Toledo International by 6.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock worth $557,680,000 after purchasing an additional 25,873 shares during the last quarter. GAMMA Investing LLC grew its stake in Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after buying an additional 385,864 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. grew its position in Mettler-Toledo International by 36.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock worth $444,327,000 after acquiring an additional 96,300 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Analyst Upgrades and Downgrades

MTD has been the subject of several research reports. Robert W. Baird lowered their price objective on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their target price for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Wall Street Zen lowered Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Finally, Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a report on Monday, April 7th. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International presently has an average rating of "Hold" and an average price target of $1,302.11.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director now owns 120 shares of the company's stock, valued at $139,191.60. This represents a 89.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Stock Up 1.1%

Shares of NYSE MTD traded up $12.49 during mid-day trading on Friday, reaching $1,157.96. 64,218 shares of the company were exchanged, compared to its average volume of 151,700. The stock has a market capitalization of $24.07 billion, a P/E ratio of 28.88, a P/E/G ratio of 3.39 and a beta of 1.38. The company's 50-day simple moving average is $1,116.31 and its 200-day simple moving average is $1,201.68. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The firm had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. During the same period in the prior year, the firm posted $8.89 EPS. The company's revenue for the quarter was down 4.6% on a year-over-year basis. As a group, equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.